Smad3 Controls β-1,3-glucuronosyltransferase 1 Expression in Rat Nucleus Pulposus Cells: Implications of Dysregulated Expression in Disc Disease

Overview

Journal Arthritis Rheum

Specialty Rheumatology

Date 2012 Jun 8

PMID 22674034

Citations 9

Authors

Qianghua Wu

Jianru Wang

Renata Skubutyte

Christopher K Kepler

Zonggui Huang

D Greg Anderson

Irving M Shapiro

Makarand V Risbud

Affiliations

Soon will be listed here.

Abstract

Objective: To study the regulation of expression of β-1,3-glucuronosyltransferase 1 (GlcAT-1), an important regulator of glycosaminoglycan (GAG) synthesis, by Smad3 in nucleus pulposus (NP) cells.

Methods: GlcAT-1 expression was examined in rat NP and anulus fibrosus (AF) cells treated with transforming growth factor β (TGFβ). The effects of Smad signaling and Smad suppression on GlcAT-1 were examined in rat NP cells. GlcAT-1 expression was analyzed in the discs of Smad3-null mice and in degenerated human NP tissue.

Results: TGFβ increased the expression of GlcAT-1 in rat NP but not rat AF cells. Suppression of GlcAT-1 promoter activity was evident with dominant-negative ALK-5 (DN-ALK-5). Cotransfection with Smad3 strongly induced promoter activity independent of TGFβ. Bioinformatics analysis indicated the presence of several Smad binding sites in the promoter; deletion analysis showed that the region between -274 and -123 bp was required for Smad3 response. DN-Smad3, Smad 3 small interfering RNA, and Smad7 strongly suppressed basal as well as TGFβ-induced promoter activity. Induction of promoter activity by Smad3 was significantly blocked by DN-Smad3; Smad7 had a very small effect. Lentiviral transduction of NP cells with short hairpin RNA Smad3 resulted in a decrease in GlcAT-1 expression and accumulation of GAG. Compared to wild-type mice, significantly lower expression of GlcAT-1 was seen in the discs of Smad3-null mice. Analysis of degenerated human NP tissue specimens showed no positive correlation between GlcAT-1 and TGFβ expression. Moreover, isolated cells from degenerated human tissue showed a lack of induction of GlcAT-1 expression following TGFβ treatment, suggesting an altered response.

Conclusion: Our findings demonstrate that in healthy NP cells, the TGFβ-Smad3 axis serves as a regulator of GlcAT-1 expression. However, an altered responsiveness to TGFβ during disc degeneration may compromise GAG synthesis.

Citing Articles

Role of macrophage in intervertebral disc degeneration.

Dou Y, Zhang Y, Liu Y, Sun X, Liu X, Li B Bone Res. 2025; 13(1):15.

PMID: 39848963 PMC: 11758090. DOI: 10.1038/s41413-024-00397-7.

Assessment of the Concentration of Transforming Growth Factor Beta 1-3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine.

Staszkiewicz R, Gladysz D, Sobanski D, Bolechala F, Golec E, Sobanska M Curr Issues Mol Biol. 2024; 46(11):12813-12829.

PMID: 39590357 PMC: 11592718. DOI: 10.3390/cimb46110763.

Signaling Mechanisms of Stem Cell Therapy for Intervertebral Disc Degeneration.

Du X, Liang K, Ding S, Shi H Biomedicines. 2023; 11(9).

PMID: 37760908 PMC: 10525468. DOI: 10.3390/biomedicines11092467.

Origin of M2 Mϕ and its macrophage polarization by TGF-β in a mice intervertebral injury model.

Kawakubo A, Miyagi M, Yokozeki Y, Nakawaki M, Takano S, Satoh M Int J Immunopathol Pharmacol. 2022; 36:3946320221103792.

PMID: 35592891 PMC: 9174651. DOI: 10.1177/03946320221103792.

TGF-β1 suppresses syndecan-2 expression through the ERK signaling pathway in nucleus pulposus cells.

Yan W, Wang X, Pei Y, Chen F, Wang J Int J Clin Exp Pathol. 2020; 11(4):2017-2024.

PMID: 31938308 PMC: 6958228.

References

Nerlich A, Bachmeier B, Boos N . Expression of fibronectin and TGF-beta1 mRNA and protein suggest altered regulation of extracellular matrix in degenerated disc tissue. Eur Spine J. 2004; 14(1):17-26. PMC: 3476681. DOI: 10.1007/s00586-004-0745-x. View

Ng L, Grodzinsky A, Patwari P, Sandy J, Plaas A, Ortiz C . Individual cartilage aggrecan macromolecules and their constituent glycosaminoglycans visualized via atomic force microscopy. J Struct Biol. 2003; 143(3):242-57. DOI: 10.1016/j.jsb.2003.08.006. View

Hiyama A, Gajghate S, Sakai D, Mochida J, Shapiro I, Risbud M . Activation of TonEBP by calcium controls {beta}1,3-glucuronosyltransferase-I expression, a key regulator of glycosaminoglycan synthesis in cells of the intervertebral disc. J Biol Chem. 2009; 284(15):9824-34. PMC: 2665104. DOI: 10.1074/jbc.M807081200. View

Shi Y, Massague J . Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003; 113(6):685-700. DOI: 10.1016/s0092-8674(03)00432-x. View

Feng H, Danfelter M, Stromqvist B, Heinegard D . Extracellular matrix in disc degeneration. J Bone Joint Surg Am. 2006; 88 Suppl 2:25-9. DOI: 10.2106/JBJS.E.01341. View

Risbud M, Guttapalli A, Stokes D, Hawkins D, Danielson K, Schaer T . Nucleus pulposus cells express HIF-1 alpha under normoxic culture conditions: a metabolic adaptation to the intervertebral disc microenvironment. J Cell Biochem. 2006; 98(1):152-9. DOI: 10.1002/jcb.20765. View

Gogate S, Nasser R, Shapiro I, Risbud M . Hypoxic regulation of β-1,3-glucuronyltransferase 1 expression in nucleus pulposus cells of the rat intervertebral disc: role of hypoxia-inducible factor proteins. Arthritis Rheum. 2011; 63(7):1950-60. PMC: 3125401. DOI: 10.1002/art.30342. View

Pfirrmann C, Metzdorf A, Zanetti M, Hodler J, Boos N . Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976). 2001; 26(17):1873-8. DOI: 10.1097/00007632-200109010-00011. View

Gouze J, Bordji K, Gulberti S, Terlain B, Netter P, Magdalou J . Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum. 2001; 44(2):351-60. DOI: 10.1002/1529-0131(200102)44:2<351::AID-ANR53>3.0.CO;2-M. View

10.

Risbud M, Di Martino A, Guttapalli A, Seghatoleslami R, Denaro V, Vaccaro A . Toward an optimum system for intervertebral disc organ culture: TGF-beta 3 enhances nucleus pulposus and anulus fibrosus survival and function through modulation of TGF-beta-R expression and ERK signaling. Spine (Phila Pa 1976). 2006; 31(8):884-90. DOI: 10.1097/01.brs.0000209335.57767.b5. View

11.

Gilbertson L, Ahn S, Teng P, Studer R, Niyibizi C, Kang J . The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells. Spine J. 2008; 8(3):449-56. DOI: 10.1016/j.spinee.2006.11.006. View

12.

Li J, Yoon S, Hutton W . Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells. J Spinal Disord Tech. 2004; 17(5):423-8. DOI: 10.1097/01.bsd.0000112084.85112.5d. View

13.

Murakami H, Yoon S, Attallah-Wasif E, Tsai K, Fei Q, Hutton W . The expression of anabolic cytokines in intervertebral discs in age-related degeneration. Spine (Phila Pa 1976). 2006; 31(16):1770-4. DOI: 10.1097/01.brs.0000227255.39896.f3. View

14.

Hayashi H, Abdollah S, Qiu Y, Cai J, Xu Y, Grinnell B . The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 1997; 89(7):1165-73. DOI: 10.1016/s0092-8674(00)80303-7. View

15.

Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y . Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol. 2007; 27(12):4488-99. PMC: 1900056. DOI: 10.1128/MCB.01636-06. View

16.

Sobajima S, Shimer A, Chadderdon R, Kompel J, Kim J, Gilbertson L . Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J. 2005; 5(1):14-23. DOI: 10.1016/j.spinee.2004.05.251. View

17.

Lutz M, Krieglstein K, Schmitt S, Ten Dijke P, Sebald W, Wizenmann A . Nerve growth factor mediates activation of the Smad pathway in PC12 cells. Eur J Biochem. 2004; 271(5):920-31. DOI: 10.1111/j.1432-1033.2004.03994.x. View

18.

Kitagawa H, Ujikawa M, Sugahara K . Developmental changes in serum UDP-GlcA:chondroitin glucuronyltransferase activity. J Biol Chem. 1996; 271(12):6583-5. DOI: 10.1074/jbc.271.12.6583. View

19.

Uchiyama Y, Guttapalli A, Gajghate S, Mochida J, Shapiro I, Risbud M . SMAD3 functions as a transcriptional repressor of acid-sensing ion channel 3 (ASIC3) in nucleus pulposus cells of the intervertebral disc. J Bone Miner Res. 2008; 23(10):1619-28. PMC: 2684157. DOI: 10.1359/jbmr.080502. View

20.

Walsh A, Bradford D, Lotz J . In vivo growth factor treatment of degenerated intervertebral discs. Spine (Phila Pa 1976). 2004; 29(2):156-63. DOI: 10.1097/01.BRS.0000107231.67854.9F. View